Oral administration of γ-glutamylcysteine increases intracellular glutathione levels above homeostasis in a randomised human trial pilot study
Objective: To determine if orally dosed γ-glutamylcysteine (γ-GC) can increase cellular glutathione (GSH) levels above homeostasis. Many chronic and age-related disorders are associated with down-regulation, or impairment, of glutamate cysteine ligase (GCL). This suggests that γ-GC supply may become...
Main Authors: | Martin Hani Zarka, Wallace John Bridge |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-04-01
|
Series: | Redox Biology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231716303718 |
Similar Items
-
The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes
by: Nady Braidy, et al.
Published: (2019-08-01) -
γ-glutamylcysteine exhibits anti-inflammatory effects by increasing cellular glutathione level
by: Yang Yang, et al.
Published: (2019-01-01) -
Study on the optimization of production for γ-glutamylcysteine and glutathione by a yeast-mutant strain
by: Sheng-Feng Lai, et al.
Published: (2006) -
Studies of γ-Glutamylcysteine production by improving yeast strains and medium compositions
by: Xin-Yi Lin, et al.
Published: (2005) -
Novel Antioxidant Therapy with the Immediate Precursor to Glutathione, γ-Glutamylcysteine (GGC), Ameliorates LPS-Induced Cellular Stress in In Vitro 3D-Differentiated Airway Model from Primary Cystic Fibrosis Human Bronchial Cells
by: Chris K. Hewson, et al.
Published: (2020-11-01)